AU2003267532A1 - PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF Alpha-SYNUCLEIN-RELATED DISEASES - Google Patents
PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF Alpha-SYNUCLEIN-RELATED DISEASESInfo
- Publication number
- AU2003267532A1 AU2003267532A1 AU2003267532A AU2003267532A AU2003267532A1 AU 2003267532 A1 AU2003267532 A1 AU 2003267532A1 AU 2003267532 A AU2003267532 A AU 2003267532A AU 2003267532 A AU2003267532 A AU 2003267532A AU 2003267532 A1 AU2003267532 A1 AU 2003267532A1
- Authority
- AU
- Australia
- Prior art keywords
- synuclein
- peptides
- alpha
- treatment
- related diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0216972.0 | 2002-07-22 | ||
GB0216972A GB0216972D0 (en) | 2002-07-22 | 2002-07-22 | Peptides and peptide derivaties for the treatment of &-synuclein-related diseases |
PCT/GB2003/003240 WO2004009625A2 (en) | 2002-07-22 | 2003-07-22 | PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF α-SYNUCLEIN-RELATED DISEASES |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003267532A1 true AU2003267532A1 (en) | 2004-02-09 |
Family
ID=9940894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003267532A Abandoned AU2003267532A1 (en) | 2002-07-22 | 2003-07-22 | PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF Alpha-SYNUCLEIN-RELATED DISEASES |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003267532A1 (en) |
GB (1) | GB0216972D0 (en) |
WO (1) | WO2004009625A2 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8697082B2 (en) | 2002-11-01 | 2014-04-15 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
US9034337B2 (en) | 2003-10-31 | 2015-05-19 | Prothena Biosciences Limited | Treatment and delay of outset of synucleinopathic and amyloidogenic disease |
US20080014194A1 (en) | 2003-10-31 | 2008-01-17 | Elan Pharmaceuticals, Inc. | Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease |
TW200509968A (en) | 2002-11-01 | 2005-03-16 | Elan Pharm Inc | Prevention and treatment of synucleinopathic disease |
US8506959B2 (en) | 2002-11-01 | 2013-08-13 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
US7358331B2 (en) | 2003-05-19 | 2008-04-15 | Elan Pharmaceuticals, Inc. | Truncated fragments of alpha-synuclein in Lewy body disease |
US7674599B2 (en) | 2003-11-08 | 2010-03-09 | Elan Pharmaceuticals, Inc. | Methods of using antibodies to detect alpha-synuclein in fluid samples |
EP2345417A1 (en) * | 2005-12-22 | 2011-07-20 | Vib Vzw | Means and methods for mediating protein interference |
US8147833B2 (en) | 2007-02-23 | 2012-04-03 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
EP2118300B1 (en) | 2007-02-23 | 2015-05-27 | Prothena Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
GB0716885D0 (en) * | 2007-08-30 | 2007-10-10 | United Arab Emirates Universit | Diagnostic agent |
AT506535B1 (en) * | 2008-02-22 | 2010-04-15 | Affiris Forschungs & Entwicklungs Gmbh | VACCINE CONTAINING ALPHA SYNUCLEIN MIMOTOPES BASED ON PEPTIDES |
CA2759118A1 (en) | 2008-04-17 | 2009-10-22 | Declion Pharmaceuticals, Inc. | Design and synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders |
EP3478311A4 (en) * | 2016-06-29 | 2021-01-06 | The Regents of the University of California | Structure-based peptide inhibitors of alpha-synuclein aggregation |
CN106854233B (en) * | 2017-03-03 | 2020-07-17 | 国家纳米科学中心 | Quasi-peptide and preparation method and application thereof |
CA3076473A1 (en) | 2017-09-20 | 2019-03-28 | Council Of Scientific And Industrial Research | Novel peptide as potent inhibitor of protein aggregation |
WO2020192754A1 (en) * | 2019-03-28 | 2020-10-01 | The Chinese University Of Hong Kong | Sumo peptides for treating neurodegenerative diseases |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004502781A (en) * | 2000-07-07 | 2004-01-29 | パナシア ファーマシューティカルズ インコーポレーテッド | Methods for preventing damage to nervous tissue and treating α-synuclein disease |
-
2002
- 2002-07-22 GB GB0216972A patent/GB0216972D0/en not_active Ceased
-
2003
- 2003-07-22 AU AU2003267532A patent/AU2003267532A1/en not_active Abandoned
- 2003-07-22 WO PCT/GB2003/003240 patent/WO2004009625A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004009625A2 (en) | 2004-01-29 |
WO2004009625A3 (en) | 2004-09-23 |
GB0216972D0 (en) | 2002-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003220317A1 (en) | Methods and drug delivery systems for the treatment of orofacial diseases | |
AU2003285091A1 (en) | Interferon antagonists useful for the treatment of interferon related diseases | |
AU2003267829A1 (en) | Peptides and methods for the control of obesity | |
WO2003072035A8 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2004041170A9 (en) | Compositions and methods for the treatment of immune related diseases | |
AU2003222347A1 (en) | Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof | |
WO2004024097A9 (en) | Compositions and methods for the treatment of immune related diseases | |
AU2003267532A1 (en) | PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF Alpha-SYNUCLEIN-RELATED DISEASES | |
AU2002346504A1 (en) | Therapeutic protein and treatments | |
AU2003289742A1 (en) | Stable therapeutic proteins | |
AU2003298911A1 (en) | Cyclosporins for the treatment of autoimmune diseases | |
AU2003295343A1 (en) | Uses of human zven proteins and polynucleotides | |
AU2003238039A1 (en) | Nasal peptide pharmaceutical formulation | |
AU2003226899A1 (en) | Human diabetes-mediating proteins | |
AU2003290886A1 (en) | Modified alpha-msh peptides and derivatives thereof | |
AU2003221096A1 (en) | Peptides, medicinal compositions containing the peptide and medicinal compositions for treating cancer | |
AU2003213898A1 (en) | Prevention and treatment of mycoplasma-associated diseases | |
AU2003252075A1 (en) | Human immunosuppressive protein | |
GB0201025D0 (en) | The treatment of degenerative diseases | |
AU2003238281A1 (en) | Two synthetic peptides for treatment and prevention of cancers | |
AU2002364757A1 (en) | Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases | |
AU2003215384A1 (en) | Microdispersion treatment of a protein or pharmaceutical | |
AU2003258550A1 (en) | Splicing-variant of the human p53 protein and use thereof in the production of pharmaceutical preparations for treating tumoural diseases | |
AU2003288127A1 (en) | DIAGNOSTIC AND THERAPEUTIC USE OF H-Rev107 PROTEIN FOR ALZHEIMER DISEASE | |
AU2003271651A1 (en) | Regulation of human pp2c-like protein phosphatase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |